CLINICAL_TRIALS
withdrawal
· 2019-03-07
Clinical Trial Update: Impact of Beta-3 Agonist on Psychological Distress and Blood Flow of the Bladder in Women With Overactive Bladder Syndrome [Phase 4]
Summary
Phase 4 clinical trial evaluating a Beta-3 agonist for psychological distress and bladder blood flow in women with overactive bladder; the study has been withdr…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: Far Eastern Memorial Hospital | Conditions: Overactive Bladder Syndrome | Phase 4 | Status: WITHDRAWN